Navigation Links
Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators

APhA Foundation Announces Interim Results from National Chronic Disease

Management Initiative

WASHINGTON, March 12 /PRNewswire-USNewswire/ -- Interim results show that participants in the Diabetes Ten City Challenge (DTCC) improved across all key clinical and patient satisfaction indicators in the early stages of the program, the American Pharmacists Association (APhA) Foundation announced today.

Initial data show a positive trend in controlling diabetes, the chronic disease that affects 21 million Americans and costs the U.S. more than $174 billion annually. The final DTCC report, due out in 2009, will include cost-savings data for DTCC employers.

The Diabetes Ten City Challenge (DTCC) is an employer-based diabetes self-management program conducted by APhA Foundation with support from GlaxoSmithKline. Since it was launched in October 2005, 31 employers in ten cities have joined forces with hundreds of pharmacists to help more than 1,000 people manage their diabetes.

Through the DTCC, employers establish a voluntary health benefit for employees, dependents and retirees with diabetes, and waive co-payments for diabetes medications and supplies if they work with a pharmacist "coach" to manage their condition in collaboration with their doctors and diabetes educators. The DTCC is modeled after other highly successful APhA programs that have proven to improve overall health, reduce absenteeism, shorten hospital stays and reduce health care costs.

"The results to date prove that this collaborative-practice model is effective for managing diabetes and replicable in diverse locations and employers," said William M. Ellis, CEO of the APhA Foundation and co-author of a peer-reviewed article on the results published in the March/April issue of the Journal of the American Pharmacists Association (JAPhA). "In years of experience with this model we have seen that when you have positive clinical outcomes and increased patient satisfaction in the early stages, the economic benefits follow."

Key Findings

The report released today analyzed aggregate data on 914 DTCC participants who were in the program at least three months as of September 30, 2007. It documented clinical improvements in all the recognized standards for diabetes care, including:

-- Decreases in laboratory measures (mean) for hemoglobin A1c (a

laboratory test showing the patient's average blood sugar control over

the previous two to three months), LDL cholesterol and blood pressure

over the initial year of the program

-- Increases in the number of participants with current influenza

vaccinations, foot examinations and eye examinations

-- 21% increase in the number of participants achieving the American

Diabetes Association goal of A1c level <7.0

-- Increase from 43.8% to 57.7% in participants achieving nationally

recognized National Cholesterol Education Program goals for LDL


-- 15.7% increase in the number of people achieving recognized goals for

systolic blood pressure

Other Key Data

-- The number of DTCC participants who felt their overall diabetes care

was "very good to excellent" increased from 39% to 87%

-- More than 97% of participants reported being "very satisfied" or

"satisfied" with diabetes care provided by DTCC pharmacists

-- The number of participants with self-management goals to control their

diabetes also increased significantly over the course of the program:

the number of people with nutrition goals increased from 22% to 66%;

the number of people with weight goals increased from 23% to 64%; and

the number of participants with exercise goals increased from 24% to


"The data show significant improvement in all clinical and diabetes care indicators measured," said Toni Fera, PharmD, principal author of an article on the results appearing in the March/April issue of the Journal of the American Pharmacists Association. "These results are consistent with data from past projects where similar clinical improvements translated to annual savings to employers in total direct medical costs for participants."

"Chronic diseases like diabetes are threatening the stability of our healthcare system," said GlaxoSmithKline President of U.S. Pharmaceuticals, Chris Viehbacher. "By focusing on patients and helping them to better understand and self-manage their condition, we can improve their health and lower costs. GSK is proud to support the Diabetes Ten City Challenge because it is a model that works and can be replicated."

How the DTCC Model Works

The APhA Foundation contracts with employers, helps establish local pharmacist networks and provides software and data analysis for the DTCC. Employers offer the voluntary employee benefit and compensate pharmacists for the care provided. Participating pharmacists, who are specially trained in diabetes care, educate participants on diabetes, diet and nutrition. These "pharmacist coaches" meet with participants regularly to help them track key diabetes indicators and manage their diabetes by eating right, exercising regularly, visiting their doctors and taking medications as prescribed.

Physicians are informed of participants' enrollment and are encouraged to share individual patient care plans with the pharmacist, who reinforces those plans in personal meetings. Pharmacists communicate with physicians after every visit and refer patients to other health care providers as needed for additional care or education.

Expanding the DTCC Model for all Chronic Diseases

An additional 50 employers and 1,300 employees are using the DTCC model through the APhA Foundation's HealthMapRx(TM) to manage many chronic diseases, such as diabetes and cardiovascular disease.

"The Diabetes Ten City Challenge provides an opportunity to transform health care delivery in local communities and drive fundamental change in the U.S. health care system," Ellis said. "Our overall goal is to make this model as widely available as possible and encourage employers to invest in helping their employees manage all chronic conditions. Our nation's health care system is broken -- we need more programs that are an investment in wellness rather than an expense for sickness."

About the APhA Foundation (

The American Pharmacists Association (APhA) Foundation, headquartered in Washington, D.C., is a non-profit organization affiliated with the American Pharmacists Association, the national professional society of pharmacists in the United States.

The APhA Foundation has expertise in designing programs that seek to create a new medication use system in the U.S. where patients, pharmacists, physicians and other health care providers collaborate to dramatically improve the cost and quality of consumer health outcomes through the safe and effective use of medications.

SOURCE American Pharmacists Association (APhA) Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator
2. Low levels of PYY hormone a very early indicator of type 2 diabetes
3. Type 2 diabetes may be caused by intestinal dysfunction
4. DFW Partnership for Peak Health Care Performance Selects Data Aggregator for Diabetes Treatment Program
5. White Hat Brands, Juvenile Diabetes Research Foundation Offer the Juice on New Partnership
6. Physicians Wellness Network and Home Access Health to Provide Medically Compliant Diabetes Testing Sold Directly to Consumers
7. Video: DIVABETIC - Makeover Your Diabetes Kicks Off 2008 Events
8. Mayo Researchers Look for Explanation Behind High Incidence of Diabetes Among Asian Indians
9. Marker for Diabetes Might Miss Early Vision Complication
10. Mayo researchers look for explanation behind high incidence of diabetes among Asian Indians
11. Randy Jackson and the American Heart Association Educate Minneapolis Area about the Connection between Type 2 Diabetes and Cardiovascular Disease
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), ... University. , Their study showed that small molecule analogs that target the functions ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... choice for innovative, patient centered orthopedic care. Led by John Vitolo, M.D., ... injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine is ...
(Date:11/30/2015)... ... November 30, 2015 , ... Newly reviewed and approved “NJ ... NJ. He has both advanced training and considerable experience in reconstructive dentistry ... expert in cosmetic dentistry. He is an active Spear Education member providing ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... Poison Control Centers’ National Poison Data System (NPDS) reveals that in 2014, someone ... 3 million cases, over two million of which were human exposure cases. , ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Ill. , Nov. 30, 2015 /PRNewswire/ ... a global biopharmaceutical leader dedicated to delivering ... and underserved medical conditions, today announced the ... Factor (Recombinant), PEGylated], an extended circulating half-life ... A based on full-length ADVATE [Antihemophilic Factor ...
(Date:11/30/2015)... --> --> ... by Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application ... Geography - Global Forecast to 2020", published by MarketsandMarkets, is ... CAGR of 5.2% during the forecast period from 2015 to ... 62 Figures spread through 167 P ages and in-depth ...
(Date:11/30/2015)... JERUSALEM , Nov. 30, 2015 Oramed ... company focused on the development of oral drug delivery ... investment agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of ... Oramed,s oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed ...
Breaking Medicine Technology: